arrow
T

Tucker, David

commonwealth scientific & industrial research organisation (csiro)
H指数:0
被引数:2

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial

西帕韦伯特(sipavibart)预防免疫低下人群COVID-19的疗效与安全性(SUPERNOVA):一项随机、对照、双盲、III期试验

2025-02-010
PRE